Cargando…
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327744/ https://www.ncbi.nlm.nih.gov/pubmed/33626863 http://dx.doi.org/10.3324/haematol.2020.271304 |
| _version_ | 1783732159115165696 |
|---|---|
| author | Kornauth, Christoph Herbaux, Charles Boidol, Bernd Guillemette, Chantal Caron, Patrick Mayerhöfer, Marius E. Poulain, Stéphanie Tournilhac, Olivier Pemovska, Tea Chong, Stephen J.F. van der Kouwe, Emiel Kazianka, Lukas Hopfinger, Georg Heintel, Daniel Jäger, Roland Raderer, Markus Jäger, Ulrich Simonitsch-Klupp, Ingrid Sperr, Wolfgang R. Kubicek, Stefan Davids, Matthew S. Staber, Philipp B. |
| author_facet | Kornauth, Christoph Herbaux, Charles Boidol, Bernd Guillemette, Chantal Caron, Patrick Mayerhöfer, Marius E. Poulain, Stéphanie Tournilhac, Olivier Pemovska, Tea Chong, Stephen J.F. van der Kouwe, Emiel Kazianka, Lukas Hopfinger, Georg Heintel, Daniel Jäger, Roland Raderer, Markus Jäger, Ulrich Simonitsch-Klupp, Ingrid Sperr, Wolfgang R. Kubicek, Stefan Davids, Matthew S. Staber, Philipp B. |
| author_sort | Kornauth, Christoph |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8327744 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83277442021-08-11 Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia Kornauth, Christoph Herbaux, Charles Boidol, Bernd Guillemette, Chantal Caron, Patrick Mayerhöfer, Marius E. Poulain, Stéphanie Tournilhac, Olivier Pemovska, Tea Chong, Stephen J.F. van der Kouwe, Emiel Kazianka, Lukas Hopfinger, Georg Heintel, Daniel Jäger, Roland Raderer, Markus Jäger, Ulrich Simonitsch-Klupp, Ingrid Sperr, Wolfgang R. Kubicek, Stefan Davids, Matthew S. Staber, Philipp B. Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-02-25 /pmc/articles/PMC8327744/ /pubmed/33626863 http://dx.doi.org/10.3324/haematol.2020.271304 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Kornauth, Christoph Herbaux, Charles Boidol, Bernd Guillemette, Chantal Caron, Patrick Mayerhöfer, Marius E. Poulain, Stéphanie Tournilhac, Olivier Pemovska, Tea Chong, Stephen J.F. van der Kouwe, Emiel Kazianka, Lukas Hopfinger, Georg Heintel, Daniel Jäger, Roland Raderer, Markus Jäger, Ulrich Simonitsch-Klupp, Ingrid Sperr, Wolfgang R. Kubicek, Stefan Davids, Matthew S. Staber, Philipp B. Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia |
| title | Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia |
| title_full | Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia |
| title_fullStr | Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia |
| title_full_unstemmed | Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia |
| title_short | Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia |
| title_sort | rationale for the combination of venetoclax and ibrutinib in t-prolymphocytic leukemia |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327744/ https://www.ncbi.nlm.nih.gov/pubmed/33626863 http://dx.doi.org/10.3324/haematol.2020.271304 |
| work_keys_str_mv | AT kornauthchristoph rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT herbauxcharles rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT boidolbernd rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT guillemettechantal rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT caronpatrick rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT mayerhofermariuse rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT poulainstephanie rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT tournilhacolivier rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT pemovskatea rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT chongstephenjf rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT vanderkouweemiel rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT kaziankalukas rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT hopfingergeorg rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT heinteldaniel rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT jagerroland rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT raderermarkus rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT jagerulrich rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT simonitschkluppingrid rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT sperrwolfgangr rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT kubicekstefan rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT davidsmatthews rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia AT staberphilippb rationaleforthecombinationofvenetoclaxandibrutinibintprolymphocyticleukemia |